Viewing Study NCT03540706


Ignite Creation Date: 2025-12-26 @ 5:24 PM
Ignite Modification Date: 2026-03-10 @ 12:17 AM
Study NCT ID: NCT03540706
Status: COMPLETED
Last Update Posted: 2023-08-07
First Post: 2018-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of the Use of CRP on the Prescription of Antibiotics in General Practitioners
Sponsor: Centre Hospitalier Intercommunal Creteil
Organization:

Study Overview

Official Title: Impact of the Use of C-reactive Protein in a Micro-method on the Prescription of Antibiotics in General Practitioners Consulting in the Office
Status: COMPLETED
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VIP
Brief Summary: Respiratory infections, including episodes of coughing with fever, are the main cause of outpatient antibiotic prescription, while a minority of them are linked to bacterial infections requiring antibiotic. These prescriptions are often performed by general practitioners. These unnecessary antibiotic contribute to increased bacterial resistance, side effects and unnecessary costs. Campaigns for the correct prescription of antibiotics have had a real but partial or transient success.

C-reactive protein micro-method (POCT-CRP) could help to differentiate between viral and bacterial infections and thus contribute to the proper use of antibiotics. The decrease in prescription of antibiotics is likely to have an even stronger positive impact in countries like France, where prescription is high.

The objective of this study is to evaluate the use of POCT-CRP in the general practitioner's office in case of suspected respiratory infection.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2018-A00242-53 OTHER ID-RCB View
AOR17072 OTHER_GRANT GIRCI IDF View